In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events.

Overview of attention for article published in this source, June 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 20 X posts from 18 X users, with an upper bound of 129,304 followers.

RT @AnnalsofIM: ICYMI from #ACPJournalClub: In #COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations,…

RT @AnnalsofIM: ICYMI from #ACPJournalClub: In #COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations,…

RT @AnnalsofIM: ICYMI from #ACPJournalClub: In #COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations,…

RT @AnnalsofIM: ICYMI from #ACPJournalClub: In #COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations,…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 16 additional X posts.